Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.52 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.52 |
| ▸ | MMP9 | P14780 | 3/20 | 0.48 |
| ▸ | MMP1 | P03956 | 2/20 | 0.48 |
| ▸ | MMP2 | P08253 | 2/20 | 0.48 |
| ▸ | MMP8 | P22894 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 4/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7174233 | 1.00 | FFAR1 (0.52) | FFAR1FFAR4MMP9MMP1MMP2 | |
| SCHEMBL6418633 | 0.89 | MMP9 (0.51) | MMP9MMP1MMP2MMP8CTSD | |
| SCHEMBL6418630 | 0.89 | MMP9 (0.51) | MMP9MMP1MMP2MMP8CTSD | |
| SCHEMBL6418631 | 0.89 | MMP9 (0.51) | MMP9MMP1MMP2MMP8CTSD | |
| SCHEMBL21214724 | 0.85 | MMP9 (0.49) | MMP9MMP1MMP2MMP8LTA4H | |
| SCHEMBL7301330 | 0.85 | MMP9 (0.60) | MMP9MMP1MMP2MMP8CTSD | |
| SCHEMBL7301335 | 0.85 | MMP9 (0.60) | MMP9MMP1MMP2MMP8CTSD | |
| SCHEMBL8303830 | 0.84 | NAMPT (0.54) | — | |
| SCHEMBL21214662 | 0.82 | MMP9 (0.46) | MMP9MMP1MMP2MMP8CTSD | |
| SCHEMBL7179042 | 0.79 | MMP9 (0.65) | MMP9MMP1MMP2MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6576664-B1 | 1-amido-2-hydroxy-substituted-indanes; suppressing production of tumor necrosis factor | BRISTOL-MYERS SQUIBB PHARMA COMPANY | 2003-06-10 | — | — | US | disclosed |